Synthetic and Immunological Studies of sTn Derivatives Carrying Substituted Phenylacetylsialic Acids as Cancer Vaccine Candidate
- 17 March 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 2 (5), 373-378
- https://doi.org/10.1021/ml100313d
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Synthetic and Immunological Studies of 5′-N-Phenylacetyl sTn to Develop Carbohydrate-Based Cancer Vaccines and to Explore the Impacts of Linkage between Carbohydrate Antigens and Carrier ProteinsBioconjugate Chemistry, 2008
- Improving the Antigenicity of sTn Antigen by Modification of Its Sialic Acid Residue for Development of Glycoconjugate Cancer VaccinesBioconjugate Chemistry, 2006
- Efficient Metabolic Engineering of GM3 on Tumor Cells by N-Phenylacetyl-d-mannosamineBiochemistry, 2006
- Synthesis and Immunological Properties of N-Modified GM3 Antigens as Therapeutic Cancer VaccinesJournal of Medicinal Chemistry, 2005
- A Stereoselective Approach for the Synthesis of α-SialosidesThe Journal of Organic Chemistry, 2001
- Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE® STn-KLH cancer vaccineBone Marrow Transplantation, 2000
- Glycosphingolipid antigens and cancer therapyCell Chemical Biology, 1997
- Sialyl Tn antigen is an independent predictor of outcome in patients with gastric cancerInternational Journal of Cancer, 1996
- Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis.JCI Insight, 1991
- Quantitive estimation of sialic acids: II. A colorimetric resorcinol-hydrochloric acid methodBiochimica et Biophysica Acta, 1957